Ariad’s Brigatinib trial

Ariad has fully enrolled the Phase 2 trial for Brigatinib. It is likly that it is much harder to get into the trial now. I have not heard of them giving ethical exemptions yet.

http://investor.ariad.com/mobile.view?c=118422&v=203&d=1&id=2087810

This entry was posted in AP26113 - brigatinib from Ariad, Brain metastases, Lung cancer, Potential Treatments, Research. Bookmark the permalink.

Leave a Reply